NIRSEVIMAB vs NITRAZEPAM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
NIRSEVIMAB vs NITRAZEPAM: Safety Overview
| Metric | NIRSEVIMAB | NITRAZEPAM |
|---|---|---|
| Total FAERS Reports | 247 | 1,165 |
| Deaths Reported | 5 | 365 |
| Death Rate | 2.0% | 31.3% |
| Hospitalizations | 149 | 466 |
| Average Patient Age | 0.3 yrs | 51.2 yrs |
| % Female Patients | 42.3% | 54.1% |
| Manufacturer | Sanofi Pasteur Inc. | N/A |
| Route | INTRAMUSCULAR | N/A |